By Tyler Sutherland
The next time you go for your flu shot, you may just receive nasal spray instead of a needle.
Health Canada has approved the nasal vaccine to be distributed by the maker AstraZeneca Canada.
FluMist is approved for the prevention of seasonal influenza in Canadians aged two to 59-years-old.
The main advantage to the nasal spray is not dealing with a needle if the person receiving the vaccine is squeamish. However, the nasal method may lead to flu symptoms in children, such as a runny nose or sore throat.
The new method isn’t to be used on people with weakened immune systems, underlying medical conditions, or pregnant women.
The U.S. has been using the spray since 2003.
